baber/WOPTO huggingface dataset:
Patent PT-1018312-E (PT)
Inventor: STOELINGA DIRK JAN
IPC: A47C17/84
Filed: 1999-12-14
Abstract: The invention relates to a drive for mechanically displacing and positioning two profile parts (2,6) relative to each other, comprising: at least one tooth path (4,5) connected to a one profile part (6), at least one toothed wheel (13,14) connected rotatably to a second profile part (2) for engaging on the tooth path, drive means (7), and a transmission mechanism for transmitting to the toothed wheel the power produced by the drive means, wherein the transmission mechanism is provided with at least one right-angled transmission. The invention also relates to a piece of furniture provided with such a drive, a profile part for assembly with the drive and a method for manufacturing such a profile part.
Patent PT-1055038-E (PT)
Inventor: BALDINI IOLE
IPC: E04D1/30
Filed: 1999-02-08
Abstract: A tile made of stiff molded synthetic resin having edges which overlap when a plurality of tiles are assembled upon a roof and an upper continuous contoured ridge along the upper edge and a lower continuous contoured ridge along the lower edge. The upper and lower ridges being stepped shape to engage with horizontal continuity when a plurality of tiles are assembled upon a roof. A through hole is provided in the lower ridge which aligns with a slot in the upper ridge to allow a screw to pass therethrough fastening two contiguous rows of tiles to a supporting structure.
Patent PT-1144314-E (PT)
Inventor: WEDEKAMP HORST
IPC: C02F1/32
Filed: 1999-12-30
Abstract: Each UV module (14) has an irradiation volume with polygonal cross section, its center (18) corresponding with that of the UV source (26) and extending up to half the spacing between sources. Individual UV modules (14) are arranged so that their centers form corner points of a polygon (20), its area being the sum of cross sectional areas (F1) of UV modules. Inter-module spacing is selected such that the cross sectional area (F2) of the irradiated volume (24) of each module is no more than ten times larger than the cross sectional area (F1) of the individual UV-module.  An Independent claim is also included for the corresponding method of UV irradiation. Emitted power is 0.5 W/cm of discharge length, flow velocity exceeding 0.25 m/s. Module diameter is 30 mm or more.  Preferred features: In a chamber, a frame holds the modules parallel in the flow direction (A) immersed in the fluid. Low pressure mercury vapor tubes are used. The lamp is amalgam doped, its diameter 2.0 cm, the inner casing tube diameter being 6 mm and at most 30 mm greater than the outer diameter of the UV source. The cross sectional area (F2) of the irradiation volume of each module exceeds 7.5 times the cross sectional area (F1) of the UV module allocated to it. The high power UV source has a 1.2 m discharge length, emitting radiant power exceeding 60 watts of UV-C per meter. The source has an outer diameter of 20 mm, preferably 30 mm. Through-flow is laminar. A power control circuit is included for the UV sources, at least two being connected to one controller. Power is regulated for constant UV irradiation, and in accordance with the UV transmission of the fluid and its flow rate. Flow rate is 0.4 m/s. Irradiation intensity at the tube surface is 60 mW/cm<2> in the waveband 200-280 nm.
Patent SG-26993-G (SG)
Title: Shielding connector
IPC: H01R13/658
Filed: 1993-03-12
Abstract: A tubular insulating cover (1), open at its both ends, has disposed therein a cylindrical shielding conductor (4) coaxial- lytherewith. First and second connector sockets are fitted into the cylindrical shielding conductor from its both ends, in which corresponding contacts of the first and second connector sockets are interconnected. The outer end faces of the first and second connector sockets each has cuttherein an annular groove for receiving a cylindrical metal cover of a mating plug. An annular contact for engagement with the cylindrical metal cover of the plug is received in each of the annular grooves and terminals of the annular contacts are connected to the cylindrical shielding conductor.
Patent IE-880048-L (IE)
Title: Container for free-flowing material
IPC: B65D5/44
Filed: 1988-01-08
Abstract: A container for free-flowing, fluid and like materials, comprising a tubular outer envelope (1; 4; 7; 13; 17) that can be closed at both ends and a tubular inner member (2; 5; 8; 14; 18) which at at least four positions spaced about the circumference of the tubular outer envelope is connected to said outer envelope, said inner member having a length that is 30-100% of the height of the container. Said container further comprises stiffening means (3; 6; 10; 15; 19) extending throughout the entire height of the container, having a relatively high stiffness or tear resistance of their own, and extending substantially in contact with the inner member. Said stiffening means can be a tube (3; 6) telescoped within the inner member or substantially rigid stiffening members (10; 15; 19) inserted into pockets formed adjacent a joint (9) between the outer envelope and the inner member and extending lengthwise of the container.
Patent IE-880154-L (IE)
Title: Bone screw
IPC: A61B17/86
Filed: 1988-01-21
Abstract: The invention relates to a bone screw with a threaded part and a screw head, characterized in that a head plate (3) is provided between shank (5) and screw head (1) and on whose centre is located said screw head and that the transition zone (2) between the head plate and the screw head is constructed as a predetermined shearing zone, which shears at a torque corresponding to 0.2 to 0.4 times the pulling off force for separating head plate (3) and shank (5).
[EP0276153A2]
Patent IE-880189-L (IE)
Title: Steroid 5-alpha-reductase inhibitors
IPC: C07C235/26
Filed: 1988-01-26
Abstract: 4-Aza-5-alpha-8(14)-17 substituted-androsten-3-ones having an 8(14), 7(8), or 16(17) double bond, optionally also having a 1(2) double bond, processes for their preparation, pharmaceutical compositions contaning them and their use in therapy as inhibitors of steroid 5-alpha-reductase.
Patent IE-900265-L (IE)
Title: Low calorie fat substitute
IPC: A23L1/00
Filed: 1990-01-24
Abstract: There is disclosed a low calorie fat substitute comprising an outer coating of a digestible fat surrounding an inner core of a low caloric or non-caloric material.
Patent IE-890273-L (IE)
Title: Use of a benzamide
IPC: A61K31/535
Filed: 1989-01-27
Abstract: The use of p-chloro-N-(2-morpholinoethyl)benzamide (I) for treating and preventing cognitive disorders to new.
Patent IE-41327-L (IE)
Title: Curable polyurethane compositions
IPC: C08L75/00
Filed: 1975-02-17
Abstract: Curable compositions are provided based on an imide group-containing compound, an amino compound and a polyurethane elastomer in specified proportions. These compositions can be cured to give articles possessing excellent impact strength.
[US4010220A]
Patent IE-42640-L (IE)
Title: Determining fibrinogen in blood
IPC: G01N33/68
Filed: 1976-02-19
Abstract: An improved composition and method for detecting fibrinogen, fibrinogen split products and/or fibrin split products in blood comprises utilizing killed, dyed Staphylococcus aureus cells which can be prepared by either of two methods. In the first method, Staphylococcus aureus organisms are incubated in a nutrient medium containing a polyalkylene glycol having a molecular weight of from 1000 to 5000 to which is added triphenyltetrazolium chloride; the growing organisms reduce the triphenyltetrazolium chloride to triphenylformazan which imparts coloration to the cells; the dyed Staphylococcus aureus cells are killed and substantially all untrapped dye is removed. In an alternate method, a suspension of Fast Black Salt K is added to a suspension of killed Staphylococcus aureus cells, and the dyed cells which result are washed to remove substantially all unfixed dye. The killed, dyed Staphylococcus aureus cells prepared by either method are suspended in an imidazole buffer to maintain a pH of 7.4. The suspension may be lyophilized if desired. The determination of fibrinogen split products and/or fibrin split products in blood serum is performed by serially diluting the blood serum test sample and adding a specified volume of reconstituted killed, dyed Staphylococcus aureus cells to an equivalent volume of each serial dilution of serum test sample, and observing the serial dilutions for the presence of visible clumping as a positive test result. Coloration of the cells greatly improves visualization of the end point of the test. The concentration of fibrinogen split products and/or fibrin split products in the blood serum test sample can be calculated if a comparison test is run with a serum containing a known amount of fibrinogen, fibrinogen split products and/or fibrin split products.
[US3990947A]
Patent IE-830467-L (IE)
Title: Monoclonal antibodies against lens epithelial cells
IPC: C07K19/00
Filed: 1983-03-04
Abstract: Disclosed are monoclonal antibodies against lens epithelial cells and methods of producing them. Continuous cell lines for producing monoclonal antibodies to lens epithelial cells are disclosed. Human lens epithelial antibody producing cells are fused with myeloma cells to provide a fused hybrid, the hybrid is cultured, and antibodies specific to human lens epithelial cells are collected. Proliferation of remnant lens epithelial cells after extracapsular extraction is prevented by instilling the monoclonal antibodies specific to lens epithelial cells into the anterior chamber of the human eye and allowed to interact with the lens epithelial cells. Complement is then instilled into the anterior chamber to cause lysis or other damage to the lens epithelial cells thereby preventing them from multiplying and migrating to cover the surface of the lens capsule left in place. This can be done at the time of extracapsular cataract extraction or later to remove a second cataract caused by proliferation of these cells. There is no damage to other parts of the eye, but only to the remnant lens epithelial cells.
[US4432751A]
Patent IE-780554-L (IE)
Title: Coupling for ostomy bags
IPC: A61B17/00
Filed: 1978-03-20
Abstract: A system is provided by which an ostomy bag can be securely coupled to an adhesive dressing that fits around the stoma and yet will permit the bag to be removed without disturbing the dressing. This system involves a first coupling member bonded to the dressing and a second coupling member bonded to the ostomy bag around the stomal opening. One coupling member consists of an upstanding rib or other projection which is dimensioned to sealingly engage an opening in the other coupling member.
[US4460363A]
Patent IE-34317-L (IE)
Title: Fruit spreads
IPC: A23L21/12
Filed: 1970-06-19
Abstract: 1318614 Fruit spreads UNILEVER Ltd 22 June 1970 [23 June 1969] 30123/70 Heading A2B A fruit spread of improved keepability is prepared by contacting whole or divided fruit with aqueous sugar syrup without cooking the fruit, to effect a preservative action and emulsifying the mixture of sugar syrup and uncooked fruit with edible oil or fat. By "uncooked fruit" is meant fruit which has not been exposed to heat for a time long enough for the individual shape of the fruit pieces to be lost. The sugar syrup may be heated to pasteurise the fruit. The oil may be aerated (e.g. with N 2 or CO 2 ) the emulsion is preferably a water-in-oil emulsion. The fruit may be used in fresh, dried or frozen form. The sugar may be sucrose, dextrose, maltose, fructose, lactose, brown sugar, invert sugar or honey. The fruit may be raisins, dates, figs, prunes, apricots, strawberries, blueberries and cherries. The oil or fat may be margarine, butter, coconut, palm kernel, cotton seed, kapok, rape seed, peanut, olive, sunflower seed, sesame, corn, safflower or soybean oil, milk fat, beef tallow or lard. The fat may be hydrogenated. Other materials which may be present in the food include emulsifiers such as mono- and di-glycerides. lecithin and polyoxythylene sorbitan derivatives; thickeners such as corn, tapioca, potato and rice starch, carboxymethylcellulose, methylcellulose, guar gum, xanthan gum, alginates and pectin; stabilisers such as sorbic, malic, phosphoric, tartaric and ethylene diamine tetraacetic acids and alkali metal salts thereof, esters of p-hydroxybenzoic acid, alkali metal propionates, butylated hydroxyanisole. butylated hydroxytoluene, and propyl gallate: flavours such as vanilla, caramel, maple, cinnamon, mint and fruit flavours; and salt, nuts, spices and colours.
[GB1318614A]
Patent IE-790843-L (IE)
Title: Oside derivatives
IPC: C07H15/18
Filed: 1979-08-08
Abstract: New process for preparing osides. This process involves the reaction of an ose substituted in position 1 by a-O-imidyl group with an ose containing only a free OH group. Application: preparation of the trisaccharide B.
[EP0004823A2]
Patent FI-844048-L (FI)
Inventor: MURRAY DANIEL J
IPC: C07C313/00
Filed: 1984-10-15
Abstract: A process for the preparation of an aromatic cyanate which comprises (a) preparing in situ a cyanogen chloride by contacting a solution of chlorine in a chlorinated hydrocarbon with an aqueous solution of an alkali metal cyanide at a temperature of 0°C or below under conditions such that a cyanogen chloride is prepared; (b) physically separating the chlorinated hydrocarbon in which the cyanogen chloride is dissolved from the aqueous layer in which an alkali metal chloride salt is dissolved; and (c) contacting the cyanogen chloride dissolved in the chlorinated hydrocarbon with a hydroxy-substituted aromatic compound dissolved in a chlorinated hydrocarbon, a secondary alcohol or a tertiary alcohol, in the presence of a tertiary amine at a temperature of about 0°C or less under conditions such that a polyaromatic cyanate is prepared.
Patent IE-781250-L (IE)
Title: HOT-FORGED Co-Cr-Mo ALLOY ARTICLES
IPC: A61L27/00
Filed: 1978-06-22
Abstract: A wrought alloy consisting of 22 to 27 weight percent chromium, 3 to 6 weight percent molybdenum, 0.10 to 0.25 weight percent nitrogen, up to 0.15 weight percent carbon, up to 1 weight per cent manganese, up to weight percent silicon, up to 2 weight percent iron, up to 2 weight percent nickel, and the balance (except for impurities and incidental constituents) cobalt. Also includes alloy articles, e.g. surgical implants, constructed of the above. Further covers hot forged alloy articles wherein the alloy consists of the ingredients stated above.
[GB2000188A]
Patent IE-871425-L (IE)
Title: Steam pressure cookers
IPC: A47J27/092
Filed: 1987-05-29
Abstract: The invention concerns a steam pressure cooking pot consisting of a container accommodating the product to be cooked, a cover with safety valve capable of being placed thereupon, a locking means clamping container and cover to one another in the closed condition, and a seal disposed between cover and container securing the inside space of the pot against a drop in pressure in the closed condition, with a sealing lip of the seal pointing radially inwardly lying against the cover or the container which, upon pressing down on the cover in the direction toward the container, lifts off from the sealing emplacement on the cover or on the container, and with the cover or container, upon subsequent movement of the cover into the opening condition, executing a relative movement toward the sealing lip. Disposed radially outside the edge of the sealing lip, between the sealing lip and the cover or the container, is a slide element that acts as a levered support for the lifting movement of the sealing lip.
[US4733795A]
Patent IE-831480-L (IE)
Title: Contraceptive composition.
IPC: A61K31/745
Filed: 1983-06-24
Abstract: A contraceptive composition for vaginal administration which contains a salt of a sulfonated styrene polymer and a pharmaceutically acceptable carrier. Effective polymers have a degree of substitution of from about 0.7 to 1.3 and an average molecular weight of between 600 and 7,000,000.
Patent IE-44122-L (IE)
Title: Thienopyridine derivatives
IPC: A61P9/08
Filed: 1976-07-08
Abstract: The present invention relates to pyridine derivatives having the formula:  (I) in which: (From US4097482 A) [FR2345150A2]
Patent IE-35883-L (IE)
Title: Dredging machine
IPC: E02F3/92
Filed: 1971-12-09
Abstract: A dredging head with a pivotally mounted mud shield and cooperating intake assembly. A head located at the end of a dredge boom has digging and conveying screw augers attached to a rotating shaft to loosen material such as mud, silt, and weeds from the bottom of a body of water and convey it toward an intake assembly which includes a suction intake conduit, a rotor, a stationary anvil, and an arcuate bar assembly. The mud shield confines material near the augers so the material can be conveyed by the augers to the rotor, stationary anvil, and arcuate bar assembly which cooperate to cut and shred the dredged material as it is pulled into the suction intake conduit. The arcuate bar assembly reinforces both suction intake conduit and stationary anvil and provides support for the rotor to prevent shaft deformation if collision with an underwater obstruction flexes the shaft against the arcuate bar assembly.
[US3738029A]
Patent IE-39906-L (IE)
Title: Fluid pressure control.
IPC: G05D16/16
Filed: 1974-07-26
Abstract: The fluid forced by a pump 1 through a conduit 2 towards a point of use such as a spraying bar 6, passes through a gate valve 7 which generates a pressure drop. The higher pressure P0 and the lower pressure P1 thus determined act on a diaphragm 10 which carries a flap valve member cooperating with a seat 18 formed at the inner end of a discharge tube 15-5 which returns the liquid to the tank from which it is pumped. An auxiliary diaphragm 17 acts in the reverse direction. As soon as the pressure difference P0 - P1 exceeds a given value, the flap valve member 14 closes. It is easily demonstrated that under such conditions the delivery pressure P1 is proportional to the pressure drop P1-P0, irrespective of the flow rate through the nozzles of the sprayer bar 6. If 1 is driven at a constant speed, P1 therefore remains constant.
[US3933277A]
Patent IE-901738-L (IE)
Title: Dihdrospirorenone as an antiandrogen
IPC: C07J21/00
Filed: 1990-05-15
Abstract: The use of <IMAGE> preferably together with an oestrogen, for the preparation of a pharmaceutical which is suitable for the treatment of hormonal irregularities in the premenopause (cycle stabilisation) and for hormone replacement therapy in the menopause, for the treatment of androgen-induced disorders and for contraception is described.
Patent IE-871745-L (IE)
Title: Analgesic compositions
IPC: A61K9/00
Filed: 1987-06-30
Abstract: A pharmaceutical composition consisting of: Ibuprofen: 33-46% w/w L-arginine: 34-51% w/w Sodium bicarbonate: 9-29% w/w is useful for preparing soluble granulate pharmaceutical preparations.
[US4834966A]
Patent IE-45670-L (IE)
Title: 17ß-HYDROXY-3-OXO-17Ó-PREGNA-4-ENE-21-CARBOXYLIC ACID-Ô-¹LACTONE
IPC: C07J21/00
Filed: 1977-08-29
Abstract: A new process for the preparation of 17 beta -hydroxy-3-oxo-17 alpha -pregn-4-ene-21-carboxylic acid gamma -lactone is described herein. The process makes use of androst-4-ene-3,17-dione as the starting material and 17 alpha -ethynyl-17 beta -hydroxyandrost-4-en-3-one as an early intermediate.
[US4057542A]
Patent IE-851836-L (IE)
Title: Photolithographic stripping method
IPC: G03F7/26
Filed: 1985-07-22
Abstract: A method is provided for stripping a contrast enhancement layer from the surface of a photoresist such as a novolak-based resist without substantially altering its characteristic properties for photolithographic applications. The CEL composite photoresist is immersed or treated with toluene or a mixture thereof in a particular manner.
[US4623611A]
Patent IE-812537-L (IE)
Title: Specific binding assay device
IPC: G01N33/542
Filed: 1981-10-29
Abstract: A homogeneous specific binding assay device, a method for its preparation, and a method for its use in determining a ligand, such as antigen, hapten, or antibody, in, or the ligand binding capacity of, a liquid sample. The test device comprises a solid carrier member, such as a fibrous web matrix, e.g., paper, or a polymeric film or gel, incorporated with reagents for a homogeneous specific binding assay system which produces a detectable response, usually an electromagnetic radiation signal, that is a function of the presence or amount of the ligand in or the ligand binding capacity of the sample. Useful homogeneous specific binding assay systems include those involving enzyme substrate labels, enzyme prosthetic group labels, and enzyme labels. The detectable response preferably is a luminescent, fluorescent, spectrophotometric, or colorimetric response, which is measurable by visual observation or instrument means.
Patent NO-823109-L (NO)
Inventor: HEGI PAUL
IPC: H04M1/274
Filed: 1982-09-14
Abstract: An automatic dialer for telephone numbers comprises a control unit (100), a memory unit (200), a keyboard unit (300), a display unit (400), units for voltage feed (550) and regulation (500), units for amplification (600) and automatic regulation of signal level (700), a signal shaping unit (900) and a unit for connection with a telephone line (800). At least the memory unit (200) is housed in a removable portion that plugs into a fixed portion containing the other units. This memory unit contains identification information corresponding to a local telephone network; and a memory of the control unit contains identification information corresponding to the local telephone network to which this fixed portion is connected. The control unit comprises a comparator comparing the identification information of a fixed portion and of the removal portion which plugs into this fixed portion, and controls modifications of the operating program of the control unit as a function of the result of this comparison.
Patent NO-830063-L (NO)
Inventor: LEMON PETER HERBERT RICHARD BR
IPC: B22C1/16
Filed: 1983-01-10
Abstract: Foundry moulds or cores are made by a method comprising mixing a granular refractory material with a potassium alkali phenol-formaldehyde resin binder solution, forming the mixture and curing the formed mixture by gassing with a 1-3C alkyl formate. Cure by gassing with a formate, particularly methyl formate, enables rapid and efficient production of foundry moulds or cores. The formates used have relatively low toxicity.
Patent NO-850198-L (NO)
Inventor: CRAIG CHARLES E
IPC: C02F1/68
Filed: 1985-01-17
Abstract: An improved hydrophobic composite is prepared by depositing on a particulate or granular core material an adherent first coat comprising a film-forming polyurethane and, optionally, asphalt, and applying to the thus-coated core material a hydrophobic colloidal oxide, such as hydrophobic fumed silica. The composites are useful in various waterproofing applications, as well as in cleaning up oil spills.
Patent NO-855078-L (NO)
Inventor: HIMMLER ADOLF
IPC: A61P37/04
Filed: 1985-12-17
Abstract: Method for producing recombinant horse and dog interferons, as well as said interferons.
Patent NO-894734-L (NO)
Inventor: FREYNE EDDY JEAN EDGARD
IPC: A61K31/517
Filed: 1989-11-28
Abstract: Novel (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives of formula <CHEM> the pharmaceutical acceptable acid addition salts thereof and the stereochemically isomeric forms thereof, wherein -X<1>=X<2>- is -CH=CH-, -CH=N-, or -N=CH-; R is hydrogen or C1-6alkyl; Y is hydrogen, C1-10alkyl, C3-7cycloalkyl, Ar<1>, Ar<2>-C1-6alkyl, C2-6alkenyl or C2-6alkynyl;  Z is a radical of formula <CHEM>   <CHEM> which compounds are useful for treating disorders which are characterized by an excessive proliferation and/or abnormal differentiation of epithelial tissues: pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.